Disclosure Of Intangible Assets [Text Block]

OSE Immunotherapeutics - Filing #5980970

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
44 010 EUR
46 401 EUR
Research and development expense
30 445 EUR
17 158 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.